New model aims to predict which lymphoma patients will stay Cancer-Free
NCT ID NCT03436602
Summary
This study aims to create a tool that can better predict which patients with follicular lymphoma will remain progression-free two years after their initial treatment. Researchers will analyze existing tumor samples and medical records from 370 patients to identify patterns linked to better or worse outcomes. The goal is to develop a more accurate prediction model than current methods, which could help doctors personalize follow-up care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FOLLICULAR LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Arcispedale Santa Maria Nuova, AUSL IRCSS, Hematology Department
Reggio Emilia, RE, 42123, Italy
-
Azienda Ospedaliera Universitaria Maggiore della Carità
Novara, 28100, Italy
-
Institute of Oncology Research
Bellinzona, Canton Ticino, 6500, Switzerland
-
Institute of Pathology
Locarno, Canton Ticino, Switzerland
Conditions
Explore the condition pages connected to this study.